Physician profile
Michael Voss Hoffman
NPI 1619903382
$293,464.47
in general payments reported to CMS, 2019-2025
12 companies · $52K in 2025
The $52K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39K · 2020: $26K · 2021: $37K · 2022: $41K · 2023: $54K · 2024: $46K · 2025: $52K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $129K · Consulting Fee: $19K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,875 · Travel and Lodging: $1,521 · Food and Beverage: $477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $128,657.35 |
| Consulting Fee | $18,875.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,875.00 |
| Travel and Lodging | $1,520.70 |
| Food and Beverage | $476.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Development Corporation | $281,323.31 | 2019-2025 | |
| Depuy Synthes Sales INC. | $11,825.23 | 2019 | |
| Davol INC. | $93.15 | 2024 | |
| Siemens Medical Solutions USA, INC. | $50.56 | 2022 | |
| Nalu Medical, INC. | $30.64 | 2025 | Nalu Neurostimulation System |
| Ferring Pharmaceuticals INC. | $28.25 | 2022-2023 | Euflexxa |
| Total Joint Orthopedics, INC. | $26.72 | 2025 | |
| Orthofix Medical, INC. | $22.31 | 2023 | Physio-Stim |
| Moximed, INC | $19.46 | 2025 | Misha Knee System, Small, Left |
| Vertex Pharmaceuticals Incorporated | $17.28 | 2025 | |
| Medtronic, INC. | $17.17 | 2021 | |
| Heron Therapeutics, INC. | $10.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.